COCP
Cocrystal Pharma, Inc.
Company overview
- Market capitalization
- $23.31M
- Employees
- 10
- Latest publication
- 2026-09-29
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 105,000USD | 225,000USD | 0USD | 0USD | 0USD | 0USD | 136,000USD | 0USD |
| Research Development | 2,142,000USD | 1,371,000USD | 1,619,000USD | 954,000USD | 1,122,000USD | 1,360,000USD | 2,037,000USD | 3,242,000USD |
| Selling General Administrative | 1,147,000USD | 1,210,000USD | 862,000USD | 1,135,000USD | 986,000USD | 942,000USD | 1,193,000USD | 1,800,000USD |
| General And Administrative Expenses | 1,147,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 3,289,000USD | 2,490,000USD | 3,875,000USD | 2,089,000USD | 2,087,000USD | 981,000USD | 3,202,000USD | 1,800,000USD |
| Operating Income | -3,184,000USD | -2,356,000USD | -2,481,000USD | -2,089,000USD | -2,108,000USD | -2,341,000USD | -3,230,000USD | -5,042,000USD |
| Total Other Income Expense Net | 20,000USD | 57,000USD | 55,000USD | 40,000USD | 53,000USD | 40,000USD | -36,000USD | 103,000USD |
| Interest Expense | -10,000USD | — | — | — | — | 37,000USD | — | 111,000USD |
| Net Income | -3,164,000USD | -2,299,000USD | -2,426,000USD | -2,049,000USD | -2,055,000USD | -2,301,000USD | -3,266,000USD | -4,939,000USD |
| Cost Of Revenue | — | 91,000USD | -1,394,000USD | 13,000USD | 21,000USD | 1,360,000USD | 28,000USD | 3,242,000USD |
| Gross Profit | — | 134,000USD | 1,394,000USD | -13,000USD | -21,000USD | -1,360,000USD | -28,000USD | -3,242,000USD |
| Interest Income | — | 22,000USD | — | 22,000USD | — | 37,000USD | — | 111,000USD |
| Net Interest Income | — | 22,000USD | 47,000USD | 22,000USD | 28,000USD | 37,000USD | 55,000USD | 111,000USD |
| Income Before Tax | — | -2,299,000USD | -2,426,000USD | -2,049,000USD | -2,055,000USD | -2,301,000USD | -3,266,000USD | -4,939,000USD |
| Net Income From Continuing Ops | — | -2,299,000USD | -2,426,000USD | -2,049,000USD | -2,055,000USD | -2,301,000USD | -3,266,000USD | -4,939,000USD |
| Ebit | — | -2,356,000USD | -2,481,000USD | -2,089,000USD | -2,108,000USD | -2,341,000USD | -3,266,000USD | -5,042,000USD |
| Ebitda | — | -2,265,000USD | -2,390,000USD | -1,850,000USD | -2,087,000USD | -2,316,000USD | -3,238,000USD | -5,012,000USD |
| Depreciation And Amortization | — | 91,000USD | 91,000USD | 239,000USD | 21,000USD | 25,000USD | 28,000USD | 30,000USD |
| Reconciled Depreciation | — | 12,000USD | 91,000USD | 239,000USD | 21,000USD | 25,000USD | 101,000USD | 99,000USD |
| Selling And Marketing Expenses | — | — | 39,000USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | — | 1,355,000USD | — | — | -1,321,000USD | — | -3,242,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 5,427,000USD | 2,014,000USD | 6,564,000USD | 0USD |
| Cost Of Revenue | 376,000USD | 12,537,000USD | 15,169,000USD | 12,392,000USD | 8,794,000USD | 6,034,000USD | 4,004,000USD | 50,000USD |
| Gross Profit | -376,000USD | -12,537,000USD | -15,169,000USD | -12,392,000USD | -8,794,000USD | -4,020,000USD | 2,560,000USD | -50,000USD |
| Research Development | 5,055,000USD | 12,537,000USD | 15,169,000USD | 12,392,000USD | 8,794,000USD | 6,034,000USD | 4,004,000USD | 58,572,000USD |
| Selling General Administrative | 3,964,000USD | 5,341,000USD | 5,990,000USD | 5,745,000USD | 5,427,000USD | 5,566,000USD | 4,863,000USD | 4,352,000USD |
| Total Operating Expenses | 9,019,000USD | 5,341,000USD | 3,390,000USD | 26,437,000USD | 5,427,000USD | 5,566,000USD | 50,966,000USD | 62,924,000USD |
| Operating Income | -9,019,000USD | -17,878,000USD | -18,559,000USD | -38,829,000USD | -14,221,000USD | -9,586,000USD | -48,406,000USD | -62,924,000USD |
| Net Interest Income | 134,000USD | 537,000USD | 460,000USD | -2,000USD | -4,000USD | -8,000USD | -19,000USD | -58,000USD |
| Income Before Tax | -8,831,000USD | -17,504,000USD | -17,984,000USD | -38,837,000USD | -14,185,000USD | -9,648,000USD | -48,169,000USD | -62,630,000USD |
| Net Income | -8,831,000USD | -17,504,000USD | -17,984,000USD | -38,837,000USD | -14,185,000USD | -9,648,000USD | -48,169,000USD | -49,048,000USD |
| Net Income From Continuing Ops | -8,831,000USD | -17,504,000USD | -18,021,000USD | -38,837,000USD | -14,185,000USD | -9,648,000USD | -48,169,000USD | -49,048,000USD |
| Ebit | -9,019,000USD | -17,878,000USD | -21,159,000USD | -18,137,000USD | -14,221,000USD | -9,586,000USD | -2,303,000USD | -62,572,000USD |
| Ebitda | -8,643,000USD | -17,752,000USD | -20,970,000USD | -17,952,000USD | -14,031,000USD | -9,429,000USD | -2,205,000USD | -62,522,000USD |
| Depreciation And Amortization | 376,000USD | 126,000USD | 189,000USD | 185,000USD | 190,000USD | 157,000USD | 98,000USD | 50,000USD |
| Reconciled Depreciation | 376,000USD | 446,000USD | 412,000USD | 388,000USD | 382,000USD | 336,000USD | 254,000USD | 50,000USD |
| Total Other Income Expense Net | 188,000USD | 374,000USD | 575,000USD | -8,000USD | 36,000USD | -62,000USD | 237,000USD | 294,000USD |
| Unclassified Operating Expenses | — | -12,537,000USD | -17,769,000USD | 8,300,000USD | -8,794,000USD | -6,034,000USD | 42,099,000USD | — |
| Income Tax Expense | — | -17,504,000USD | -1USD | 8,000USD | 4,000USD | 8,000USD | 19,000USD | -13,582,000USD |
| Interest Expense | — | — | — | 2,000USD | 4,000USD | 8,000USD | 19,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -38,837,000USD | -14,185,000USD | -9,648,000USD | -48,169,000USD | -49,048,000USD |
| Tax Provision | — | — | — | — | — | 0USD | 0USD | -13,582,000USD |
| Non Operating Income Net Other | — | — | — | — | — | -54,000USD | 256,000USD | 352,000USD |
| Interest Income | — | — | — | — | — | — | 237,000USD | 248,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,649,000USD | 7,426,000USD | 9,712,000USD | 10,446,000USD | 8,505,000USD | 10,659,000USD | 13,456,000USD | 16,233,000USD |
| Total Current Assets | 3,236,000USD | 5,939,000USD | 8,134,000USD | 8,782,000USD | 6,765,000USD | 8,826,000USD | 11,580,000USD | 14,256,000USD |
| Other Current Assets | 256,000USD | 493,000USD | 403,000USD | 540,000USD | 357,000USD | 460,000USD | 505,000USD | 584,000USD |
| Total Liabilities | 3,605,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,616,000USD | 2,229,000USD | 2,210,000USD | 1,520,000USD | 1,831,000USD | 1,931,000USD | 2,428,000USD | 1,948,000USD |
| Total Stockholder Equity | 1,044,000USD | 4,116,000USD | 6,331,000USD | 7,669,000USD | 5,333,000USD | 7,304,000USD | 9,523,000USD | 12,703,000USD |
| Total Equity Including Noncontrolling Interest | 1,044,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,299,000USD | 1,392,000USD | 1,483,000USD | 1,574,000USD | 1,652,000USD | 1,747,000USD | 1,847,000USD | 1,948,000USD |
| Accounts Payable | 1,892,000USD | 1,371,000USD | 890,000USD | 745,000USD | 856,000USD | 808,000USD | 1,542,000USD | 859,000USD |
| Short Term Debt | 352,000USD | 343,000USD | 334,000USD | 326,000USD | 317,000USD | 309,000USD | 301,000USD | 293,000USD |
| Common Stock | 13,000USD | 13,000USD | 13,000USD | 13,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Retained Earnings | -347,712,000USD | -344,548,000USD | -342,249,000USD | -339,823,000USD | -337,774,000USD | -335,719,000USD | -333,418,000USD | -330,152,000USD |
| Total Liab | — | 3,310,000USD | 3,381,000USD | 2,777,000USD | 3,172,000USD | 3,355,000USD | 3,933,000USD | 3,530,000USD |
| Other Current Liab | — | 515,000USD | 986,000USD | 449,000USD | 658,000USD | 814,000USD | 585,000USD | 796,000USD |
| Capital Stock | — | 13,000USD | 13,000USD | 13,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Cash | — | 4,685,000USD | 7,025,000USD | 7,729,000USD | 4,766,000USD | 6,921,000USD | 9,860,000USD | 13,020,000USD |
| Cash And Short Term Investments | — | 4,685,000USD | 7,025,000USD | 7,729,000USD | 4,766,000USD | 6,921,000USD | 9,860,000USD | 13,020,000USD |
| Net Debt | — | -3,261,000USD | -5,520,000USD | -6,146,000USD | -3,108,000USD | -5,188,000USD | -8,054,000USD | -11,145,000USD |
| Short Long Term Debt Total | — | 1,424,000USD | 1,505,000USD | 1,583,000USD | 1,658,000USD | 1,733,000USD | 1,806,000USD | 1,875,000USD |
| Net Receivables | — | 761,000USD | 706,000USD | 513,000USD | 1,642,000USD | 1,445,000USD | 1,215,000USD | 652,000USD |
| Property Plant Equipment Gross | — | 3,405,000USD | 3,484,000USD | 3,562,000USD | 3,627,000USD | 3,702,000USD | 3,776,000USD | 3,849,000USD |
| Common Stock Shares Outstanding | — | 13,786,000shares | 11,290,000shares | 10,991,000shares | 10,174,000shares | 10,174,000shares | 10,174,000shares | 10,174,000shares |
| Non Current Assets Total | — | 1,487,000USD | 1,578,000USD | 1,664,000USD | 1,740,000USD | 1,833,000USD | 1,876,000USD | 1,977,000USD |
| Non Current Liabilities Total | — | 1,081,000USD | 1,171,000USD | 1,257,000USD | 1,341,000USD | 1,424,000USD | 1,505,000USD | 1,582,000USD |
| Non Currrent Assets Other | — | 95,000USD | 95,000USD | 90,000USD | 88,000USD | 86,000USD | 29,000USD | 29,000USD |
| Net Working Capital | — | 3,710,000USD | 5,924,000USD | 7,262,000USD | 4,934,000USD | 6,895,000USD | 9,152,000USD | 12,308,000USD |
| Unclassified Non Current Liabilities | — | 1,081,000USD | 1,171,000USD | 1,257,000USD | 1,341,000USD | 1,424,000USD | 1,505,000USD | 1,582,000USD |
| Unclassified Equity | — | 348,638,000USD | 348,554,000USD | 347,466,000USD | 343,087,000USD | 343,003,000USD | 342,921,000USD | 342,835,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 9,712,000USD | 13,456,000USD | 31,259,000USD | 40,840,000USD | 79,392,000USD | 54,242,000USD | 28,531,000USD | 68,562,000USD |
| Other Current Assets | 403,000USD | 505,000USD | 1,848,000USD | 2,318,000USD | 618,000USD | 449,000USD | 219,000USD | 220,000USD |
| Total Liab | 3,381,000USD | 3,933,000USD | 4,875,000USD | 1,273,000USD | 1,843,000USD | 1,737,000USD | 2,823,000USD | 1,674,000USD |
| Total Stockholder Equity | 6,331,000USD | 9,523,000USD | 26,384,000USD | 39,567,000USD | 77,549,000USD | 52,505,000USD | 25,708,000USD | 66,888,000USD |
| Other Current Liab | 986,000USD | 585,000USD | 1,800,000USD | 362,000USD | 731,000USD | 484,000USD | 495,000USD | 513,000USD |
| Common Stock | 13,000USD | 10,000USD | 10,000USD | 8,000USD | 8,000USD | 71,000USD | 36,000USD | 30,000USD |
| Capital Stock | 13,000USD | 10,000USD | 10,000USD | 8,000USD | 98,000USD | 71,000USD | 36,000USD | 30,000USD |
| Retained Earnings | -342,249,000USD | -333,418,000USD | -315,914,000USD | -297,930,000USD | -259,093,000USD | -244,908,000USD | -235,260,000USD | -187,091,000USD |
| Cash | 7,025,000USD | 9,860,000USD | 26,353,000USD | 37,144,000USD | 58,705,000USD | 33,010,000USD | 7,418,000USD | 2,723,000USD |
| Cash And Short Term Investments | 7,025,000USD | 9,860,000USD | 26,353,000USD | 37,144,000USD | 58,705,000USD | 33,010,000USD | 7,418,000USD | 2,723,000USD |
| Total Current Assets | 8,134,000USD | 11,580,000USD | 29,091,000USD | 40,178,000USD | 59,323,000USD | 34,015,000USD | 8,281,000USD | 2,943,000USD |
| Total Current Liabilities | 2,210,000USD | 2,428,000USD | 3,262,000USD | 1,216,000USD | 1,545,000USD | 1,358,000USD | 2,286,000USD | 1,557,000USD |
| Net Debt | -5,520,000USD | -8,054,000USD | -24,500,000USD | -36,847,000USD | -58,171,000USD | -32,414,000USD | -6,601,000USD | -2,392,000USD |
| Short Term Debt | 334,000USD | 301,000USD | 240,000USD | 240,000USD | 236,000USD | 217,000USD | 280,000USD | 428,000USD |
| Short Long Term Debt Total | 1,505,000USD | 1,806,000USD | 1,853,000USD | 297,000USD | 534,000USD | 596,000USD | 817,000USD | 331,000USD |
| Net Receivables | 706,000USD | 1,215,000USD | 890,000USD | 716,000USD | 0USD | 556,000USD | 644,000USD | — |
| Accounts Payable | 890,000USD | 1,542,000USD | 1,222,000USD | 614,000USD | 578,000USD | 657,000USD | 1,511,000USD | 616,000USD |
| Property Plant Equipment Net | 1,483,000USD | 1,847,000USD | 2,122,000USD | 616,000USD | 931,000USD | 1,089,000USD | 1,108,000USD | 384,000USD |
| Property Plant Equipment Gross | 3,484,000USD | 3,776,000USD | 3,925,000USD | 2,230,000USD | 2,360,000USD | 1,089,000USD | 1,108,000USD | 384,000USD |
| Common Stock Shares Outstanding | 11,290,000shares | 10,174,000shares | 9,651,000shares | 8,143,000shares | 7,689,083shares | 4,796,250shares | 3,053,458shares | 2,334,083shares |
| Non Current Assets Total | 1,578,000USD | 1,876,000USD | 2,168,000USD | 662,000USD | 20,069,000USD | 20,227,000USD | 20,250,000USD | 65,619,000USD |
| Non Current Liabilities Total | 1,171,000USD | 1,505,000USD | 1,613,000USD | 57,000USD | 298,000USD | 379,000USD | 537,000USD | 117,000USD |
| Non Currrent Assets Other | 95,000USD | 29,000USD | 46,000USD | 46,000USD | 46,000USD | 46,000USD | 50,000USD | 40,000USD |
| Net Working Capital | 5,924,000USD | 9,152,000USD | 25,829,000USD | 38,962,000USD | 57,778,000USD | 32,657,000USD | 5,995,000USD | 1,386,000USD |
| Unclassified Non Current Liabilities | 1,171,000USD | 1,505,000USD | 1,613,000USD | — | — | — | — | — |
| Unclassified Equity | 348,554,000USD | 342,921,000USD | 342,278,000USD | 337,481,000USD | 336,536,000USD | 297,271,000USD | 260,896,000USD | 254,902,000USD |
| Other Assets | — | — | 1USD | 0USD | 46,000USD | 544,000USD | 50,000USD | 40,000USD |
| Good Will | — | — | — | 0USD | 19,092,000USD | 19,092,000USD | 19,092,000USD | 65,195,000USD |
| Inventory | — | — | — | 75,000USD | — | 50,000USD | 50,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | — | 0USD | -983,000USD |
| Net Tangible Assets | — | — | — | 39,567,000USD | 58,457,000USD | 33,413,000USD | 6,616,000USD | 1,693,000USD |
| Current Deferred Revenue | — | — | — | — | 719,000USD | 423,000USD | 488,000USD | 464,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 379,000USD | 537,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 24,000USD |
| Stock Based Compensation | 176,000USD |
| Change To Account Receivables | -35,000USD |
| Change To Liabilities | 388,000USD |
| Change In Working Capital | 583,000USD |
| Operating Cash Flow | -4,856,000USD |
| Change In Cash | -4,856,000USD |
| End Cash Flow | 2,244,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,299,000USD | -2,426,000USD | -2,049,000USD | -2,055,000USD | -2,301,000USD | -3,266,000USD | -4,939,000USD | -5,343,000USD |
| Depreciation | 12,000USD | 13,000USD | 13,000USD | 21,000USD | 25,000USD | 101,000USD | 277,000USD | 33,000USD |
| Stock Based Compensation | 84,000USD | 56,000USD | 48,000USD | 84,000USD | 82,000USD | 85,000USD | 253,000USD | 148,000USD |
| Other Non Cash Items | -2,000USD | 847,701USD | -142,000USD | -148,000USD | -745,000USD | -68,000USD | -69,000USD | -73,000USD |
| Change To Account Receivables | -54,999USD | 740,000USD | 1,171,703USD | -198,000USD | -229,000USD | -563,000USD | 425,000USD | -74,000USD |
| Change In Working Capital | -135,000USD | 621,000USD | 629,353USD | -57,000USD | -745,000USD | -12,000USD | -645,000USD | 1,536,000USD |
| Total Cash From Operating Activities | -2,340,000USD | -1,736,000USD | -1,548,648USD | -2,155,000USD | -2,939,000USD | -3,160,000USD | -5,123,000USD | -3,699,000USD |
| Capital Expenditures | 0USD | 0USD | -12,561USD | 0USD | 0USD | -175USD | -59USD | -59USD |
| Free Cash Flow | -2,340,000USD | -1,736,000USD | -1,561,210USD | -2,155,000USD | -2,939,000USD | -3,160,000USD | -5,123,000USD | -3,699,000USD |
| Change In Cash | -2,340,000USD | -704,000USD | 2,963,000USD | -2,155,000USD | -2,939,000USD | -3,160,000USD | -5,123,000USD | -3,699,000USD |
| Begin Period Cash Flow | 7,100,000USD | 7,804,000USD | 4,841,000USD | 6,996,000USD | 9,935,000USD | 13,095,000USD | 18,218,000USD | 21,917,000USD |
| End Period Cash Flow | 4,760,000USD | 7,100,000USD | 7,804,000USD | 4,841,000USD | 6,996,000USD | 9,935,000USD | 13,095,000USD | 18,218,000USD |
| Total Cash From Financing Activities | — | 1,032,000USD | 4,540,559USD | — | — | 0USD | 0USD | 0USD |
| Issuance Of Capital Stock | — | 5,215,000USD | — | — | — | 0USD | 0USD | — |
| Other Cashflows From Financing Activities | — | -4,183,000USD | 4,337,000USD | — | — | — | -59USD | 59USD |
| Investments | — | — | -12,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | — | — | -12,563USD | — | — | 178USD | 466USD | 59USD |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 525USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,831,000USD | -17,504,000USD | -17,984,000USD | -38,837,000USD | -14,185,000USD | -9,648,000USD | -48,169,000USD | -49,048,000USD |
| Depreciation | 72,000USD | 126,000USD | -1,388,000USD | 388,000USD | 190,000USD | 157,000USD | 98,000USD | 50,000USD |
| Stock Based Compensation | 270,000USD | 643,000USD | 801,000USD | 855,000USD | 724,000USD | 662,000USD | 351,000USD | 562,000USD |
| Other Non Cash Items | 3,000USD | 110,000USD | 1,563,000USD | 18,871,000USD | -195,000USD | -177,000USD | -133,000USD | 53,611,000USD |
| Change To Account Receivables | 509,000USD | -325,000USD | -174,000USD | -716,000USD | 556,000USD | 88,000USD | -644,000USD | -644,000USD |
| Change In Working Capital | 294,000USD | 140,000USD | 2,342,000USD | -2,712,000USD | 796,000USD | -878,000USD | 443,000USD | 117,000USD |
| Total Cash From Operating Activities | -8,192,000USD | -16,485,000USD | -14,666,000USD | -21,435,000USD | -12,719,000USD | -9,830,000USD | -1,563,000USD | -8,290,000USD |
| Capital Expenditures | -12,000USD | -8,000USD | -118,000USD | -74,000USD | -52,000USD | -240,000USD | -145,000USD | -28,000USD |
| Free Cash Flow | -8,204,000USD | -16,493,000USD | -14,784,000USD | -21,509,000USD | -12,771,000USD | -10,070,000USD | -1,708,000USD | -8,318,000USD |
| Total Cashflows From Investing Activities | -12,000USD | -8,000USD | -118,000USD | -74,000USD | -52,000USD | -240,000USD | -145,000USD | 1,372,000USD |
| Total Cash From Financing Activities | 5,369,000USD | 0USD | 3,993,000USD | -27,000USD | 38,466,000USD | 35,662,000USD | 6,424,000USD | 8,893,000USD |
| Issuance Of Capital Stock | 5,369,000USD | 0USD | 4,000,000USD | 4,000,000USD | 38,505,000USD | 35,783,000USD | 6,638,000USD | 7,684,000USD |
| Change In Cash | -2,835,000USD | -16,493,000USD | -10,791,000USD | -21,536,000USD | 25,695,000USD | 25,592,000USD | 4,716,000USD | 1,975,000USD |
| Begin Period Cash Flow | 9,935,000USD | 26,428,000USD | 37,219,000USD | 58,755,000USD | 33,060,000USD | 7,468,000USD | 2,752,000USD | 777,000USD |
| End Period Cash Flow | 7,100,000USD | 9,935,000USD | 26,428,000USD | 37,219,000USD | 58,755,000USD | 33,060,000USD | 7,468,000USD | 2,752,000USD |
| Other Cashflows From Financing Activities | 5,369,000USD | — | 0USD | -74,000USD | -52,000USD | -240,000USD | 6,424USD | 228,000USD |
| Unclassified Financing Cash Flow | -5,369,000USD | — | — | -3,926,000USD | — | — | — | — |
| Investments | — | -8,000USD | -71,000USD | -74,000USD | -52,000USD | -240,000USD | -145,000USD | 1,400,000USD |
| Net Borrowings | — | 0USD | -7,000USD | -27,000USD | -39,000USD | -121,000USD | -214,000USD | 981,000USD |
| Change To Inventory | — | — | — | 716,000USD | -217,000USD | 919,000USD | -919,000USD | — |
| Change To Liabilities | — | — | — | -1,037,000USD | 217,000USD | -919,000USD | 919,000USD | 240,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | 35,783,000USD | 6,638,000USD | 7,912,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 25,592,000USD | 4,716,000USD | 1,975,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | 45,847,000USD | -13,582,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 1,400,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -1,400,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.